ABSTRACT
Objective To study the clinical efficacy and complications of ultraselective endovascular embolization combined with local sclerotherapy in the treatment of large hemangioma in children,to provide a better choice for the treatment.Methods 85 cases of large hemangioma in our department in the last three years were analyzed retrospectively.Patients were divided into two groups according to the treatment:the simple treatment group (33 cases),ultraselective endovascular embolization,and the combination treatment group (52 cases),ultraselective endovascular embolization combined with local sclerotherapy or local sclerotherapy after endovascular embolization.The total effective rate and the incidence of complications between two groups were compared,and the patients were followed up for 3 months to 1.5 years.Results 85 cases of large hemangioma were successfully treated by simple ultraselective endovascular embolization or combined treatment.A total of 75 cases were treated effectively (complete cure,partial cure,condition improved)and 10 cases were ineffective and no recurrence or tumor enlargement in the follow-up .In the total effective rate,the combination treatment group [96.2% (50/52)]was superior to the simple treatment group [75.8% (25/33)](χ2=6.245,P=0.012 ).There was no significant difference in the complete cure rate between the two groups (χ2=1.561,P=0.212 ).The complication rate in the simple treatment group was slightly higher than that in the combined treatment group:36.4% (12/33)vs 32.7% (17/52)(χ2=0.064,P=0.996).Conclusion The total effective rate of ultraselective endovascular embolization combined with local sclerotherapy in the treatment of large hemangioma in children is better than simple endovascular embolization,and less complications,safely treatment and less trauma.It can be used as the first choice for treatment of large hemangioma.
ABSTRACT
Objective:To retrospectively evaluate the safety,technical success rate,and effectiveness of ultratranscatheter tumor feeding arterial embolization with ethanol and lipidol for SHCC,and to explore the new therapy for SHCC. Methods:To 95 cases carry out hepatic selective arterial angiography for SHCC by CT or MRI be diagnosed and clinical very doubt be SHCC,after was diagnosed by DSA,to transcatheter ultraselective subsegmental feeding artery with microcatheter for tumor,employ ethanol and lipidol (1/1) to full fill embolized 143 tumors. Results:Technical success rate was 100% for the ultraselective subsegmental feeding artery transcatheter and embolizatoin in SHCC,There were no major complications in all cases.Before embolization ,the diameter of tumors were 0.5~3cm,average diameter 2.3 cm. after tumors were embolized,average diameter 1.2 cm. The 1,3and 5 year recurrence rates were 19%(18/95),27%(26/95),37%(35/95),and the survival rates were 100%(95/95),85%(81/95),67%(64/95) respectively. Conclusion:Its effectiveness was very notable,there were no major complications and recurrence rates was less than surgical resection in ultraselective transcatheter tumor feeding arterial embolization with ethanol and lipidol for SHCC,It should become the first selective therapy for SHCC.